NASDAQ · Financial Statements
Revolution Medicines, Inc. (RVMD) Financial Statements
$188.12
NASDAQ: RVMD
Market Cap $39.99B
Overview Financials Dividend Revolution Medicines, Inc. most recently reported annual revenue of $0, net profit of $-1.1B. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $29.0M $35.0M $12.0M $0 $0 Operating Profit $-188.0M $-258.0M $-487.0M $-690.0M $-1.2B Net Profit $-187.0M $-249.0M $-436.0M $-600.0M $-1.1B EPS $-2.47 $-3.08 $-3.86 $-3.58 $-5.95 Op Margin -639.7% -730.0% -4207.1% — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $738.0M $812.0M $2.1B $2.6B $2.4B Total Liabilities $135.0M $127.0M $236.0M $293.0M $723.0M Cash $108.0M $161.0M $696.0M $543.0M $384.0M Borrowings $67.0M $64.0M $88.0M $136.0M $159.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-147.0M $-224.0M $-351.0M $-557.0M $-898.0M Investing Cash Flow $-149.0M $-35.0M $-350.0M $-565.0M $102.0M Financing Cash Flow $3.0M $3.0M $837.0M $0 $0 Net Cash Flow $5.0M $53.0M $535.0M $-153.0M $-158.0M Free Cash Flow $-154.0M $-235.0M $-358.0M $-568.0M $-914.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.42 EV / EBITDA -25.81 FCF Yield -2.80% Quick Ratio 11.38 Interest Coverage -27.42 Return 1Y 344.62% Return 3Y 729.39% Return 5Y 650.56%
Screens featuring this stock